IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 154 filers reported holding IMMUNOGEN INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,004,745 | +97.9% | 126,323 | +135.3% | 0.00% | – |
| Q2 2023 | $1,013,055 | +135.0% | 53,686 | -40.3% | 0.00% | – |
| Q4 2018 | $431,000 | -97.4% | 89,863 | -94.8% | 0.00% | -100.0% |
| Q2 2018 | $16,901,000 | -39.9% | 1,737,000 | -35.0% | 0.01% | -35.7% |
| Q1 2018 | $28,114,000 | +45.9% | 2,672,400 | -11.1% | 0.01% | +55.6% |
| Q4 2017 | $19,272,000 | -10.4% | 3,006,600 | +7.0% | 0.01% | -18.2% |
| Q3 2017 | $21,503,000 | +747.9% | 2,810,900 | +197.0% | 0.01% | +1000.0% |
| Q3 2016 | $2,536,000 | -13.0% | 946,301 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $2,915,000 | -63.8% | 946,301 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $8,062,000 | -37.2% | 946,301 | 0.0% | 0.00% | -42.9% |
| Q4 2015 | $12,841,000 | +41.4% | 946,301 | 0.0% | 0.01% | +75.0% |
| Q3 2015 | $9,084,000 | -27.7% | 946,301 | +8.3% | 0.00% | -33.3% |
| Q2 2015 | $12,569,000 | – | 874,050 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |